RECALL: Brilliant Blue G Recall

The FDA has received reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G (BBG) during eye surgeries. The BBG dye was supplied by Franck's Compounding Lab in Ocala, FL. Franck's Pharmacy issued a recall letter on March 9, 2012, of all lots of Brilliant Blue G:

  • 08232011@80
  • 10132011@6
  • 10112011@82
  • 10192011@125

Brilliant Blue G is not an approved drug in the U.S. Healthcare professionals are to immediately quarantine and return any remaining Brilliant Blue G products.

For more information visit http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm296383.htm.